Real World Hematologic Toxicities in Patients > 70 versus < 69 with ER Positive Metastatic Breast Cancer on CDK 4/6 Inhibitors: Single Institution Retrospective Study

Presenter Information

C. Olazagasti MD, Lead Author
W. Liu
C. Lee PharmD
T. Decina
K. Pappas
K. Cheng MD

Facility

NS/LIJ

Department

Division of Hematology/Oncology, Department of Medicine

Status

Fellow

Category

Clinical Science Research

Start Date

3-6-2020 12:00 AM